These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 32284362)

  • 1. COVID-19 and neuromuscular disorders.
    Guidon AC; Amato AA
    Neurology; 2020 Jun; 94(22):959-969. PubMed ID: 32284362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic.
    Brownlee W; Bourdette D; Broadley S; Killestein J; Ciccarelli O
    Neurology; 2020 Jun; 94(22):949-952. PubMed ID: 32241953
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network.
    Solé G; Salort-Campana E; Pereon Y; Stojkovic T; Wahbi K; Cintas P; Adams D; Laforet P; Tiffreau V; Desguerre I; Pisella LI; Molon A; Attarian S;
    Rev Neurol (Paris); 2020 Jun; 176(6):507-515. PubMed ID: 32354651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Against pandemic research exceptionalism.
    London AJ; Kimmelman J
    Science; 2020 May; 368(6490):476-477. PubMed ID: 32327600
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 will change MS care forever - No.
    Preziosa P; Rocca MA; Filippi M
    Mult Scler; 2020 Sep; 26(10):1149-1151. PubMed ID: 32567471
    [No Abstract]   [Full Text] [Related]  

  • 6. Doctor-Should I get the COVID-19 vaccine? Infection and immunization in individuals with neuromuscular disorders.
    Živković SA; Gruener G; Narayanaswami P;
    Muscle Nerve; 2021 Mar; 63(3):294-303. PubMed ID: 33471383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of "Novel Pharmacology" in the Treatment of COVID-19 and Potential Psychiatric Risks.
    Yahya AS; Khawaja S; Chukwuma J
    Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32441496
    [No Abstract]   [Full Text] [Related]  

  • 8. Keeping standards of multiple sclerosis care through the COVID-19 pandemic.
    Sastre-Garriga J; Tintoré M; Montalban X
    Mult Scler; 2020 Sep; 26(10):1153-1156. PubMed ID: 32552382
    [No Abstract]   [Full Text] [Related]  

  • 9. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1.
    Mikuls TR; Johnson SR; Fraenkel L; Arasaratnam RJ; Baden LR; Bermas BL; Chatham W; Cohen S; Costenbader K; Gravallese EM; Kalil AC; Weinblatt ME; Winthrop K; Mudano AS; Turner A; Saag KG
    Arthritis Rheumatol; 2020 Aug; 72(8):1241-1251. PubMed ID: 32349183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridging the Gap at Warp Speed - Delivering Options for Preventing and Treating Covid-19.
    Slaoui M; Greene SE; Woodcock J
    N Engl J Med; 2020 Nov; 383(20):1899-1901. PubMed ID: 32931679
    [No Abstract]   [Full Text] [Related]  

  • 11. QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine.
    Monzani A; Genoni G; Scopinaro A; Pistis G; Kozel D; Secco GG
    Eur J Clin Invest; 2020 Jun; 50(6):e13258. PubMed ID: 32356580
    [No Abstract]   [Full Text] [Related]  

  • 12. Tracking a Vaccine and Developing Therapeutics for COVID-19.
    Gould KA
    Dimens Crit Care Nurs; 2020; 39(6):293-297. PubMed ID: 33009266
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of central nervous system demyelinating diseases during the coronavirus disease 2019 pandemic: a practical approach.
    ApÓstolos-Pereira SL; Silva GD; Disserol CCD; Feo LB; Matos AMB; Schoeps VA; Gomes ABAGR; Boaventura M; Mendes MF; Callegaro D
    Arq Neuropsiquiatr; 2020 Jul; 78(7):430-439. PubMed ID: 32609290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19: endgames.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2020 May; 20(5):511. PubMed ID: 32311325
    [No Abstract]   [Full Text] [Related]  

  • 15. Anthony Fauci, MD, on COVID-19 Vaccines, Schools, and Larry Kramer.
    Abbasi J
    JAMA; 2020 Jul; 324(3):220-222. PubMed ID: 32511680
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.
    Ramaswamy SB; Govindarajan R
    J Neuromuscul Dis; 2020; 7(3):361-364. PubMed ID: 32508329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré Syndrome Associated with SARS-CoV-2.
    Toscano G; Palmerini F; Ravaglia S; Ruiz L; Invernizzi P; Cuzzoni MG; Franciotta D; Baldanti F; Daturi R; Postorino P; Cavallini A; Micieli G
    N Engl J Med; 2020 Jun; 382(26):2574-2576. PubMed ID: 32302082
    [No Abstract]   [Full Text] [Related]  

  • 18. Developing Covid-19 Vaccines at Pandemic Speed.
    Lurie N; Saville M; Hatchett R; Halton J
    N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
    [No Abstract]   [Full Text] [Related]  

  • 19. Nanotechnology versus coronavirus.
    Nat Nanotechnol; 2020 Aug; 15(8):617. PubMed ID: 32764720
    [No Abstract]   [Full Text] [Related]  

  • 20. Covid-19: Human challenge studies will see people purposefully infected with virus.
    Mahase E
    BMJ; 2020 Oct; 371():m4101. PubMed ID: 33093016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.